Table 6 Association of SUA and cardiovascular mortality via fine-gray competing risk model

Whole population (N=1593)

Continuous per 1 unit increase

1.14 (1.08-1.21)

<0.001

1.10 (1.03-1.17)

0.006

Tertile 1 (<5.5 mg/dL)

Reference

--

Reference

--

Tertile 2 (5.5-7.0 mg/dL)

0.94 (0.82-1.08)

0.370

0.94 (0.82-1.08)

0.410

Tertile 3 (>7.0 mg/dL)

1.12 (1.03-1.21)

0.007

1.06 (0.97-1.17)

0.200

Men (N=897, 56.3%)

Continuous per 1 unit increase

1.17 (1.09-1.26)

<0.001

1.17 (1.08-1.27)

<0.001

Tertile 1 (<5.9 mg/dL)

Reference

--

Reference

--

Tertile 2 (5.9-7.4 mg/dL)

0.97 (0.81-1.16)

0.740

1.01 (0.84-1.22)

0.900

Tertile 3 (>7.4 mg/dL)

1.21 (1.09-1.35)

<0.001

1.19 (1.05-1.35)

0.006

Women (N=696, 43.7%)

Continuous per 1 unit increase

1.10 (1.00-1.20)

0.044

0.98 (0.87-1.10)

0.690

Tertile 1 (<5.1 mg/dL)

Reference

--

Reference

--

Tertile 2 (5.1-6.5 mg/dL)

1.05 (0.87-1.28)

0.590

0.93 (0.75-1.14)

0.460

Tertile 3 (>6.5 mg/dL)

1.08 (0.95-1.22)

0.260

0.90 (0.77-1.06)

0.200